AccessibilityHelp
BICO Group logo

BICO Group(OTC) BCCOY

Market Cap$185.02MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-95%
5 Year-95%
1 Year-11%
1 Month+14%
$0.67
-5.26%
-0.04Today
BICO Group last closing stock price
MetricPriceDate
Last closeUSD 0.672026-10-19
BICO Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+32.11%USD 0.512026-09-23
1 month+14.05%USD 0.592026-09-15
3 month+81.57%USD 0.372026-07-15
Year to date+20.55%USD 0.562025-12-29
1 year-10.72%USD 0.752025-10-15
3 year-14.78%USD 0.792023-10-17
5 year-95.48%USD 14.802021-10-04
Since inception-95.48%USD 14.802021-09-29

BICO Group Financials at a Glance

Market Cap

$185.02MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 1.50B

Net Income (TTM)

-SEK 830.67M

EPS (TTM)

-$0.31

P/E Ratio

-2.13

Dividend

$0.00

Beta (Volatility)

0.56 (Low)

Price

$0.67

Volume

300

Open

$0.67

Previous Close

$0.67

Daily Range

$0.67 - $0.67

52-Week Range

$0.35 - $0.75

Estimated Earnings Date

Apr 27, 2026

BCCOY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BICO Group

BICO Group AB (publ) is a leading bio-convergence company based in Gothenburg, Sweden, specializing in innovative solutions for the medical and biotechnology sectors. Established in 2016, BICO operates globally, focusing on advanced laboratory solutions and bioautomation technologies.

Products and Services
  • 3D bioprinters and hybrid microscopes for advanced research
  • Precision dispensing and biosensor technologies for industrial applications
  • Specialized services in 3D cell culture and digital pathology
Growth Outlook
  • Revenue increased to SEK 346.5 million in Q2 2026, showing strong demand
  • Gross profit margin improved to 46.8% in Q2 2026, indicating operational efficiency
  • Expansion into North America and Asia enhances market reach and growth potential
Financial Highlights
  • Trailing twelve-month revenue of SEK 1.4 billion, reflecting robust sales growth
  • Operating income margin improved to -9.8% in Q2 2026, signaling operational improvements
  • Cash and cash equivalents stood at SEK 626 million as of June 2026, ensuring liquidity
BICO Group AB (publ) is positioned at the forefront of the bio-convergence industry, offering a diverse range of products and services that cater to the evolving needs of the medical and biotechnology sectors. The company's commitment to innovation is evident in its advanced laboratory solutions and bioautomation technologies, which are essential for modern scientific research and industrial applications. The growth outlook for BICO is promising, with significant revenue increases and improved gross profit margins indicating a strong operational performance. The company's strategic expansion into key markets, particularly in North America and Asia, is expected to further enhance its growth trajectory. Financially, BICO has demonstrated resilience, with a substantial trailing twelve-month revenue and a solid cash position that supports ongoing operations and potential investments. The improvements in operating income margins reflect the company's focus on enhancing efficiency and profitability. Overall, BICO Group AB (publ) presents a compelling opportunity for investors interested in the bio-convergence sector, driven by innovation and a strong market presence.
AI Generated • Oct 23, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

602

CEO

Maria Ada Eufemia Forss, MBA

Website

bico.com

Headquarters

Gothenburg, VG 412 63, SE

BCCOY Financials

Key Financial Metrics (TTM)

Gross Margin

45.61%

Operating Margin

-11.37%

Net Income Margin

-55.79%

Return on Equity

-49.84%

Return on Capital

-7.28%

Return on Assets

-29.64%

Earnings Yield

-46.95%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$185.02MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

276.30M

Volume

300

Avg. Volume

14.169

Financials (TTM)

Gross Profit

SEK 684.75M

Operating Income

-SEK 171.37M

EBITDA

-SEK 995.96M

Operating Cash Flow

SEK 7.90M

Capital Expenditure

-SEK 17.45M

Free Cash Flow

-SEK 9.55M

Cash & ST Invst.

SEK 626.02M

Total Debt

SEK 684.97M

BICO Group Performance Analysis

BICO Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 209,567,42543.1%
20232023-12-31SEK 189,375,529-9.6%
20242024-12-31SEK 163,363,659-13.7%
20252025-12-31SEK 152,658,541-6.6%
BICO Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3017.6%
Q42025-12-3116.0%
Q12026-03-31-25.4%
Q22026-06-305.0%
BICO Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK -0.30180.7%
20232023-12-31SEK -0.3929.1%
20242024-12-31SEK -0.00-99.5%
20252025-12-31SEK -0.3921750.0%
BICO Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-3096.3%
Q42025-12-3190.5%
Q12026-03-31-124.4%
Q22026-06-3070.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

SEK 346.49M

+6.9%

Gross Profit

SEK 162.26M

+13.9%

Gross Margin

46.83%

N/A

Market Cap

$185.02MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$266.21K

N/A

Employees

695

N/A

Net Income

-SEK 38.35M

+79.2%

EBITDA

SEK 13.50M

+130.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

SEK 626.02M

+837.6%

Total Debt

SEK 684.97M

-51.3%

Accounts Receivable

SEK 281.29M

+790.9%

Inventory

SEK 207.18M

-11.3%

Long Term Debt

SEK 625.32M

+151.7%

Short Term Debt

SEK 59.65M

-94.8%

Return on Assets

-29.64%

N/A

Return on Invested Capital

-7.30%

N/A

Free Cash Flow

-SEK 65.00M

-91.2%

Operating Cash Flow

-SEK 59.05M

-109.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GWINGlorywin Entertainment Group, Inc.
$0.66+0.00%
LABStandard BioTools Inc.
$0.60-0.92%
HBIOHarvard Bioscience, Inc.
$8.32+1.09%
CLGNCollPlant Biotechnologies Ltd.
$3.75+2.18%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$12.59-16.95%
EWZiShares - iShares Msci Brazil ETF
$34.15-19.82%
ITUBItaú Unibanco
$7.70-20.37%
XPXP
$15.71-48.36%

Questions About BCCOY

What is the current price of BICO Group?

BICO Group is trading at $0.67 per share.

What is the 52-week range for BICO Group?

Over the past 52 weeks, BICO Group has traded between $0.35 and $0.75.

How much debt does BICO Group have?

As of the most recent reporting period, BICO Group reported total debt of SEK 70.95M.

How much cash does BICO Group have on hand?

BICO Group reported SEK 64.85M in cash and cash equivalents in its most recent financial results.

What is BICO Group’s dividend yield?

BICO Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services